MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders
MediPharm Labs held its annual shareholder meeting on June 26, 2024, with 337 shareholders representing 14.72% of the company's issued shares. All resolutions were passed by a ballot vote.
The election of directors saw Michael Bumby, Chris Halyk, David Pidduck, Shelley Potts, and Chris Taves elected for the upcoming year. Voting results indicated strong support for Chris Halyk (93.15%) and David Pidduck (91.15%).
MNP LLP was appointed as the company's auditor until the next annual meeting, with 97.42% of votes in favor.
- Strong shareholder participation with 14.72% of shares represented.
- Chris Halyk received significant support with 93.15% votes.
- David Pidduck secured 91.15% votes, showing strong confidence from shareholders.
- MNP LLP's reappointment as auditor with 97.42% votes in favor indicates strong trust in financial oversight.
- Michael Bumby received a relatively lower support with 57.30% votes.
There were 337 Shareholders represented virtually or by proxy at the Meeting holding 59,605,486 common shares, representing
1. Election of Directors
Each of the nominees for election as directors were elected as directors of MediPharm Labs for the ensuing year or until their successors are elected or appointed. Voting results for the election of the individual directors are as set out below:
Nominee | Votes For | Votes Withheld | ||
# | % | # | % | |
Michael Bumby | 34,006,743 | 57.304 | 25,337,458 | 42.696 |
Chris Halyk | 55,278,278 | 93.149 | 4,065,923 | 6.851 |
David Pidduck | 54,094,062 | 91.153 | 5,250,139 | 8.847 |
Shelley Potts | 54,033,383 | 91.051 | 5,310,818 | 8.949 |
Chris Taves | 54,786,218 | 92.319 | 4,557,983 | 7.681 |
The Company's Board of Directors continues to be composed almost entirely of Independent Directors, with David Pidduck being the only Executive Director.
2. Appointment of Auditor
MNP LLP, Chartered Professional Accountants, was appointed as auditor of MediPharm Labs until the next annual meeting of the holders of the Shareholders at remuneration to be fixed by the directors. Voting results are as set out below:
Votes For | Votes Withheld | ||
# | % | # | % |
58,061,900 | 97.418 | 1,538,874 | 2.582 |
About MediPharm Labs
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. MediPharm Labs develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets.
In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment License from Health Canada, becoming the only company in
In 2023, MediPharm acquired VIVO Cannabis Inc. which expanded MediPharm's reach to medical patients in
View original content to download multimedia:https://www.prnewswire.com/news-releases/medipharm-labs-announces-voting-results-from-the-2024-annual-meeting-of-shareholders-302183666.html
SOURCE MediPharm Labs Corp.
FAQ
What were the results of the 2024 MediPharm Labs annual shareholder meeting?
How many shareholders participated in the MediPharm Labs 2024 annual meeting?
Who were the directors elected at the 2024 MediPharm Labs meeting?
How many votes did Chris Halyk receive in the 2024 MediPharm Labs election?